Atlas Trials

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

Clinical trial NCT01045798 · TERMINATED

Trial details

NCT number
NCT01045798
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Invasive Candidiasis
Start date
2010-12-01
Primary completion
2012-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.